Program at a Glance

Day 1 (May 7, Thu)
Day 1 (May 7, Thu)
Time Room A
(Vista Hall 1)
Room B
(Vista Hall 2+3)
Room C
(Grand Hall 1)
13:00-13:10 Opening
13:10-13:50 Plenary Lecture I The Global Burden of Allergic Diseases:
WAO Strategies for a Healthier Future
13:50-14:10 Coffee Break
14:10-15:40 KAAACI-WAO Symposium Global Strategies for Asthma & Allergy: Evolving Concepts from Origins to Future Technologies Symposium I Advances in Hypereosinophilic Disorders KOR KAAACI-KATRD Airway Symposium Ⅰ A Comprehensive Ecosystem for Airway Diseases:
Lifespan, Guidelines, and Rehabilitation
15:40-16:00 Break
16:00-17:30 Symposium II Multidimensional Drivers of Atopic Dermatitis: Biology, Microbiome Ecology, Environment Working Group Symposium I Neurobiology of Chronic Cough: Translating Science into Clinical Impact KOR KAAACI-KATRD Airway Symposium Ⅱ The Spectrum of Advanced Airway Diseases:
Systemic Overlaps and Structural Changes
17:30-17:50 Break
17:50-18:30 Sponsored Symposium I
(GSK Korea) The Clinical Impact of IL-5 Inhibition in Severe Eosinophilic Asthma: Can Mepolizumab Modify Disease Course?
Sponsored Symposium II
(Takeda) Beyond Attacks: Disease Control in HAE with Lanadelumab
Sponsored Symposium III
(AstraZeneca Korea) Tezepelumab in Severe Asthma: From Downstream to Upstream Targeting
Day 2 (May 8, Fri)
Day 2 (May 8, Fri)
Time Room A
(Vista Hall 1)
Room B
(Vista Hall 2+3)
Room C
(Grand Hall 1)
Room D
(Grand Hall 4+5)
09:00-09:40 Plenary Lecture II Viral Exacerbations of Asthma and COPD: Shared Triggers and Treatments
09:40-10:20 Plenary Lecture III Treatable Traits in Severe Airway Disease: A Personalized Approach to Biologics
10:20-10:40 Coffee Break
10:40-12:10 KAAACI-EAACI Symposium Precision Approaches in Allergen Immunotherapy: From Evidence to Real-World Practice KAAACI-Interasma Symposium I Heterogeneity in Severe Asthma: Omics-Driven Insights and Evolving Endotypes Symposium III Allergic Rhinitis and Chronic Rhinosinusitis: Evolving Mechanisms and Targeted Therapeutic Strategies KORSymposium IV Artificial Intelligence in Allergy & Immunology: From Fundamentals to Precision Medicine
12:10-12:20 Break
12:20-13:00 Sponsored Symposium IV
(Sanofi-Aventis Korea) Rethinking Asthma Management with Dupilumab: Insights into Airway Remodeling
Sponsored Symposium V
(Celltrion Pharm)Introduction of 1st Omalizumab Biosimilar (Omlyclo) and Treatment Strategy for CSU
Sponsored Symposium VI
(GSK Korea)Time to SITT Up and Act for Asthma: Can Single Inhaler Triple Therapy Achieve Clinical Remission in Asthma?
13:00-13:50 Coffee Break & Poster Discussion(Q&A) I
13:50-14:30 Plenary Lecture IV Unraveling the Heterogeneity of Chronic Urticaria: From Pathogenesis to Precision Medicine
14:30-14:50 Break KORAllied Health Professional (AHP) Symposium
(14:30-17:20)
Break
14:50-16:20 Oral Presentation I Asthma & Immunology Oral Presentation II Upper Airway & Pediatric Allergy KOROral Presentation III Asthma & Chronic Cough
16:20-16:30 Coffee Break Coffee Break
16:30-18:00 KAAACI-AAIAT Symposium Real-World Perspectives on Allergic and Immunologic Diseases in Asia Symposium V Updates in Chronic Urticaria: Pathogenesis, Comorbidities, and Treatment Beyond Omalizumab KORHealthcare Policy Directions for Severe Asthma in Korea
(16:30-17:10)
KORPublic Hearing on Guidelines for Biologics in Severe Asthma
(17:10-18:40)
18:00-18:40 Sponsored Symposium VII
(Novartis Korea) Inside the Mast Cell: Why selective BTK targeting matters
Sponsored Symposium VIII
(Sanofi-Aventis Korea) Latest Scientific Updates in CRSwNP: Focusing on Type 2 inflammation and Asthma Comorbidity
Sponsored Symposium Ⅸ
(Lilly Korea) EBGLYSS 4U: Turn AD Down and Keep It Down
18:40-20:00 Gala Dinner (Walker Hall, 1F)
Day 3 (May 9, Sat)
Day 3 (May 9, Sat)
Time Room A
(Vista Hall 1)
Room B
(Vista Hall 2+3)
Room C
(Grand Hall 1)
Room D
(Grand Hall 4+5)
07:30-08:30 Meet the Expert I
(Grand Hall 4)
Exacerbations of Asthma and COPD: Future Prospects
Meet the Expert II
(Grand Hall 5)
How High is Too High:
a Case-based Approach
Meet the Expert III
(Grand Hall 6)
Translating Basic Science to Clinical Impact in Chronic Cough
Meet the Expert Ⅳ
(Pine Room)
Monitoring Asthma in Children in Real Life
08:30-09:00 Coffee Break
09:00-09:40 Plenary Lecture V Delabeling Drug Allergy: A Global Strategy for Antimicrobial Stewardship and Patient Safety
09:40-10:20 Plenary Lecture VI Central Mechanisms of Chronic Cough Hypersensitivity
10:20-10:40 Coffee Break
10:40-12:10 Oral Presentation IVEnvironmental & Systemic Allergy Oral Presentation VPediatric Allergy & Chronic Cough KOROral Presentation VI Airway Disease KOROral Presentation VIIFood & Drug Allergy, Urticaria
12:10-12:20 Break
12:20-13:00 Sponsored Symposium Ⅹ
(Novartis Korea) Remibrutinib in CU: Clinical Outcomes and Lessons from Early Real-World Use
Sponsored Symposium XI
(AstraZeneca Korea) Precision Medicine in Severe Eosinophilic Asthma: Role of Benralizumab
Sponsored Symposium XII
(Celltrion Pharm) Definition and Characteristics of Biosimilar, Clinical Use Experience
13:00-13:50 Coffee Break & Poster Discussion(Q&A) II
13:50-14:30 Plenary Lecture VII Precision Medicine for HES: From Phenotype to Genotype
14:30-14:50 Break
14:50-16:20 KAAACI-Interasma Symposium II Severe Asthma Linking Endotypes to Airway Remodeling Working Group Symposium II Hypersensitivity to Cancer Therapies and Biologic Agents KOR Symposium VI Integrating National Research and Registry Data to Advance Asthma Care Across the Lifespan
16:20-16:30 Closing Ceremony

위로 가기